COMPLETED

An App-based Instructional Platform to Improve Eye Drop Recall

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this interventional study is to assess whether an in-office, language-concordant instructional app improves drop regimen recall in a population of glaucoma patients who are on multi-drop regimens. Participants will be divided into two groups -- those who use the app and those who do not. The app will have narrated information regarding the drop regimen, a quiz to test understanding of the regimen, and will enable a graphical printout of the eye drops and schedule. At one month, both groups will be assessed on their eye drop regimen recall.

Official Title

Assessing the Effects of an In-office, Language-concordant App on Eye Drop Recall in Patients With Multi-drop Regimens

Quick Facts

Study Start:2024-09-01
Study Completion:2025-06-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:COMPLETED

Study ID

NCT06045390

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * patients with a diagnosis of glaucoma (any type)
  2. * drop regimen of at least 2 pressure-lowering drops
  3. * languages supported at this time: English, Spanish, Cantonese
  1. * concurrent eye conditions necessitating additional eye drops
  2. * inability to self-administer eye drops
  3. * inability to engage with app (either visual or other barrier)

Contacts and Locations

Principal Investigator

Frank Brodie, MD
PRINCIPAL_INVESTIGATOR
UCSF, Department of Ophthalmology

Study Locations (Sites)

San Francisco General Hospital
San Francisco, California, 94110
United States

Collaborators and Investigators

Sponsor: University of California, San Francisco

  • Frank Brodie, MD, PRINCIPAL_INVESTIGATOR, UCSF, Department of Ophthalmology

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-09-01
Study Completion Date2025-06-01

Study Record Updates

Study Start Date2024-09-01
Study Completion Date2025-06-01

Terms related to this study

Additional Relevant MeSH Terms

  • Glaucoma